All four findings are addressed in the current spec, plan, tasks, and demo-repo-plan:

1. **PC-AGENT-ROUTE pass/partial requirement for first happy-path success**  
   - Spec Minimum Bar: “PC-AGENT-ROUTE is pass or partial and backed by recorder-observed OpenCode/GSD/MiniMax evidence”  
   - SC-009: “At least one happy-path CTO-visible feature packet has PC-AGENT-ROUTE: pass or partial backed by recorder-observed OpenCode/GSD/MiniMax evidence before demo success is claimed.”

2. **Codex-authored contamination audit for backfilled/existing features**  
   - FR-015: “Existing or backfilled feature candidates MUST be audited for Codex-authored feature behavior before they can be used as CTO-visible OpenCode/GSD route proof.”  
   - Demo-repo-plan Feature PR Requirements: “audit whether existing/backfilled feature behavior or repairs were Codex-authored before using the feature as CTO-visible OpenCode/GSD route proof.”

3. **P0 route/provenance blockers block proof until fixed and rerun/observed**  
   - Spec Minimum Bar: “If a P0 sdp-trace recorder or product blocker prevents PC-AGENT-ROUTE from being supported …, first-packet success is blocked until the product issue is fixed and the route is rerun or otherwise observed with retained evidence.”  
   - FR-014: “P0 sdp-trace product blockers that prevent route/provenance or evidence proof MUST be fixed before claiming a feature packet; P1 and lower issues MAY be recorded for follow-up unless they block the proof.”

4. **Prompt text/digest validation for each feature**  
   - FR-016: “Every feature packet MUST retain prompt text or prompt digest metadata sufficient to check that the developer prompt did not ask OpenCode/GSD to maintain sdp-trace evidence or close packet rows.”  
   - SC-008: “A reviewer can inspect the retained task prompt or prompt digest metadata and confirm it did not ask OpenCode/GSD to manufacture or maintain sdp-trace evidence.”  
   - Demo-repo-plan Feature PR Requirements repeats the same verification step.

No new critical or major findings remain.

**NO CRITICAL OR MAJOR FINDINGS**
